Nonlinear Dynamics to Distribute GeneBio’s Phenyx Worldwide
Geneva, Switzerland, and Newcastle, UK – June 2nd, 2008 – Geneva Bioinformatics (GeneBio) SA and Nonlinear Dynamics today announced a worldwide distribution agreement for GeneBio’s Phenyx and Nonlinear’s Progenesis LC-MS software, whereby Nonlinear will distribute GeneBio’s Phenyx MS identification platform. This partnership exploits the complementary technology of Phenyx and the novel Progenesis LC-MS software for label-free quantitative analysis.
Under the terms of the agreement, Nonlinear will distribute Phenyx both as a standalone software package and alongside the Progenesis LC-MS software. The synergy between the two products, Phenyx for MS-MS identification and Progenesis LC-MS for quantitative analysis, offers customers a unique and comprehensive solution building on the extensive reputations of the two companies in the field of proteomics.
Developed in collaboration with the Swiss Institute of Bioinformatics (SIB), Phenyx is GeneBio’s renowned software platform for the identification and characterization of proteins and peptides from mass spectrometry data, specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment while offering a flexible user experience and an adaptable architecture to help instil confidence in results assessment. (http://phenyx.vital-it.ch/pwi)
Based on the ground breaking technological approach pioneered by the Progenesis SameSpots software for 2D gel image analysis, Progenesis LC-MS is a highly innovative research solution for quantitative analysis of label-free LC-MS data. It applies simple workflows to complex data-sets so that the researcher can quickly generate reliable conclusions from their research and gain confidence in their results.
Will Dracup, CEO of Nonlinear Dynamics said, “We are delighted to enter into this agreement with GeneBio as the Phenyx MS protein characterization software provides the final link in the quantitative LC-MS analysis workflow we have developed. Our novel approach to LC-MS analysis uses sophisticated and intelligent algorithms to rapidly analyse the LC-MS data and accurately highlight the significantly changing peptides which require further investigation by MS-MS. Nonlinear are highly enthusiastic about this partnership with GeneBio who are well respected in this area of MS research The option to add the Phenyx software platform to this analysis approach gives our customers a robust, flexible and integrated solution to their MS identification requirements.”
“This is a major step forward for Phenyx and GeneBio; we are very motivated about what this distribution deal will bring,” said Nasri Nahas, CEO of GeneBio. “Our two companies have known and respected each other for quite some time. Nonlinear’s reputation in the bioinformatics field, their extended clientele and distribution network are all first-class; this deal allows us to bring Phenyx even closer to the MS community, especially when bundled with an innovative tool like Progenesis LC-MS. We look forward for the great upsides this new collaboration will bring to both parties and to the successful expansion of our Phenyx business.”
For more information concerning this distribution deal and for Phenyx and Progenesis LC-MS product demonstrations, please visit the GeneBio and Nonlinear’s booths, respectively numbers 27 and 73, at the upcoming ASMS Conference on Mass Spectrometry in Denver, Colorado, from June 1-5.
About GeneBio
Geneva Bioinformatics (GeneBio) SA is a leading bioinformatics company providing the life science community with world-class proteomics software that bridges the gap between information gathering and knowledge generation. Established in 1997, GeneBio focuses its expertise on protein identification and characterization as well as proteome imaging, offering clients and partners a high degree of specialization essential to proteomics research. Close ties to academic peers and a thorough network of distribution and strategic partners give the company both unfettered access to scientific excellence and recognized market presence so that we may best serve the scientific community. For more information about GeneBio, please visit: www.genebio.com.
About Nonlinear Dynamics Ltd
We strive to solve your challenges in the fields of Proteomics and Biomarker Discovery. This comes from a core strength in developing innovative, high quality data analysis solutions. Our product range includes analysis software for 1D and 2D electrophoresis gels, Mass Spectrometry (MS) and LC-MS as well as tools for multivariate statistical analysis. The revolutionary SameSpots technology is unique to Nonlinear. It transforms the ability of what you can achieve with proteomics – providing faster accurate quantitation, enabling cross lab reproducibility and making robust reliable statistical analysis available to everyone.
“Everything about Nonlinear Dynamics makes it a great company to work with…”
Merry L. Lindsey, Ph.D., Assistant Professor
University of Texas Health Science Center at San Antonio
Nonlinear sells and supports its products through its UK headquarters and its USA office, as well as a global network of partners and OEM resellers.
